<code id='2E3CDBC1D5'></code><style id='2E3CDBC1D5'></style>
    • <acronym id='2E3CDBC1D5'></acronym>
      <center id='2E3CDBC1D5'><center id='2E3CDBC1D5'><tfoot id='2E3CDBC1D5'></tfoot></center><abbr id='2E3CDBC1D5'><dir id='2E3CDBC1D5'><tfoot id='2E3CDBC1D5'></tfoot><noframes id='2E3CDBC1D5'>

    • <optgroup id='2E3CDBC1D5'><strike id='2E3CDBC1D5'><sup id='2E3CDBC1D5'></sup></strike><code id='2E3CDBC1D5'></code></optgroup>
        1. <b id='2E3CDBC1D5'><label id='2E3CDBC1D5'><select id='2E3CDBC1D5'><dt id='2E3CDBC1D5'><span id='2E3CDBC1D5'></span></dt></select></label></b><u id='2E3CDBC1D5'></u>
          <i id='2E3CDBC1D5'><strike id='2E3CDBC1D5'><tt id='2E3CDBC1D5'><pre id='2E3CDBC1D5'></pre></tt></strike></i>

          leisure time

          leisure time

          author:hotspot    Page View:87523
          UnitedHealth Group
          UnitedHealth Group’s Optum will pay $3.3 billion total for the home health giant Amedisys. Jim Mone/AP

          Home health and hospice chain Amedisys has chosen a new corporate owner.

          Amedisys and UnitedHealth Group’s Optum agreed to a deal Monday in which UnitedHealth will pay $101 per share in cash for Amedisys, totaling $3.3 billion. UnitedHealth’s latest offer is $1 per share higher than what it proposed in its unsolicited buyout offer a few weeks ago.

          advertisement

          Option Care Health, a company that delivers intravenous medicines and mails health care supplies to people’s homes, originally offered to acquire Amedisys in May in an all-stock deal. However, the attractiveness of that deal deteriorated after Option Care’s stock price plummeted soon after the company made its bid.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          New air purifier tech could be key to improving indoor air quality
          New air purifier tech could be key to improving indoor air quality

          AdobeUntiltheearly20thcentury,Americaregularlyexperiencedbrutallydestructiveurbanfires.Conflagration

          read more
          Readout Newsletter: Biogen, Ionis, Johnson & Johnson news
          Readout Newsletter: Biogen, Ionis, Johnson & Johnson news

          AdobeTheneed-to-knowthismorningBiogen and IonisPharmaceuticals are endingtheirdevelopment ofanexperi

          read more
          Alkermes shareholders re
          Alkermes shareholders re

          MarkLennihan/APAlkermesshareholdersvotedThursdaytore-electallofthedrugmaker’scurrentdirectors,ending

          read more

          Boston hospital trains restaurant workers on naloxone for overdoses

          AlexHogan/STATBOSTON— ThetablessetupneartheentranceoftheBigNightLiveconcertvenuelookedlikeatypicalme